Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

368
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
368
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

329
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
329
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

354
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
354
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

817
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
817
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

339
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
339
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.3K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Hoffmann Reflex.

NeuroSci·2026
Same author

Multisystem regulation of reward and addiction: beyond the dopaminergic system.

Frontiers in pharmacology·2026
Same author

Restless Legs Syndrome: A Network Model of Iron-Dependent Neuromodulation-A Narrative Review.

Brain sciences·2026
Same author

Differential Processing of a <i>Bacillus subtilis</i> GH5 Endoglucanase During Yeast Surface Display in <i>Saccharomyces cerevisiae</i>.

Microorganisms·2026
Same author

Regulatory Variation at TERT and TERC Shows Limited Association with Early-Onset Alzheimer's Disease in Carriers of the Mexican Founder Mutation <i>PSEN1</i> A431E.

Medical sciences (Basel, Switzerland)·2026
Same author

Gene expression meta-analysis in the prefrontal cortex: unraveling biological underpinnings of suicidal risk.

BMC psychiatry·2026

Related Experiment Video

Updated: Apr 13, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.5K

Lower uric Acid linked with cognitive dysfunction in the elderly.

Edna Méndez-Hernández, José Salas-Pacheco, Luis Ruano-Calderón

  • 1Hospital General Dr. Manuel Gea Gonzalez, Unidad de Trastornos del Movimiento y Sueno (TMS), Mexico City, Mexico. arias@ciencias.unam.mx.

CNS & Neurological Disorders Drug Targets
|May 1, 2015
PubMed
Summary
This summary is machine-generated.

Lower serum uric acid levels correlate with cognitive dysfunction in the elderly. In a Mexican population, higher uric acid is linked to reduced dementia risk, suggesting a complex role in brain health.

More Related Videos

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

4.6K
Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
14:57

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology

Published on: March 23, 2011

95.5K

Related Experiment Videos

Last Updated: Apr 13, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.5K
Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

4.6K
Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
14:57

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology

Published on: March 23, 2011

95.5K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Gerontology

Background:

  • Uric acid is traditionally linked to cardiovascular disease risk.
  • Emerging evidence suggests uric acid acts as an antioxidant in the brain.
  • Cognitive dysfunction involves vascular and oxidative stress, but the uric acid link is unclear.

Purpose of the Study:

  • To investigate the association between serum uric acid levels and cognitive function in elderly individuals.
  • To explore the potential neuroprotective role of uric acid in cognitive health.

Main Methods:

  • Cross-sectional study involving 62 elderly subjects.
  • Serum uric acid levels were measured.
  • Cognitive function was assessed.
  • Statistical analyses were adjusted for age, sex, and cardiovascular risk factors.

Main Results:

  • Lower serum uric acid levels were significantly associated with cognitive dysfunction.
  • In a Mexican population subset, higher uric acid levels correlated with a decreased risk of dementia.

Conclusions:

  • Serum uric acid levels may be a biomarker for cognitive function in the elderly.
  • The findings suggest a potentially protective role for uric acid in the brain, contrasting with its cardiovascular associations.
  • Further research is needed to elucidate the dual role of uric acid in systemic and neurological health.